Mucinex Fast-max Tablet, Coated
Pricing Report NDC 63824-237-21

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

The latest wholesale acquisition cost for Mucinex Fast-max Cold, Flu And Sore Throat (NDC 63824-237-21) is $0.61176 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jun 19, 2024.

As a a human over the counter drug provided by Reckitt Benckiser Llc, this medication is distributed in a 2 BLISTER PACK in 1 CARTON / 10 TABLET, COATED in 1 BLISTER PACK configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.61176
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Jun 19, 2024
Data Status
As of Jul 03, 2024
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
B - Brand
Package NDC
63824-237-21
Description
2 BLISTER PACK in 1 CARTON / 10 TABLET, COATED in 1 BLISTER PACK
Generic Benchmark
The generic equivalent rate is $0.10371 (Effective: Jun 19, 2024)
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Oct 2018, the NADAC wholesale price for (NDC ) has moved within a range of $0.49750 to $0.61832 per EA. Over this 5 years and 8 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.4975 - $0.6183
Market Volatility
24.29% Variance
Latest Trend
1.06%
Date Unit Price Unit Source Method Rate
Jun 19, 2024 $0.61176 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jun 19, 2024 $0.61176 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jun 19, 2024 $0.61176 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jun 19, 2024 $0.61176 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
May 22, 2024 $0.61832 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
May 22, 2024 $0.61832 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Feb 21, 2024 $0.60335 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Feb 21, 2024 $0.60335 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Feb 21, 2024 $0.60335 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Feb 21, 2024 $0.60335 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Feb 21, 2024 $0.60335 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Feb 21, 2024 $0.60335 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Apr 01, 2022 $0.58438 EAC/I - Chain or Independent PharmacyCode 2, 6B - Brand
Apr 01, 2022 $0.58438 EAC/I - Chain or Independent PharmacyCode 2, 6B - Brand
Apr 01, 2022 $0.58438 EAC/I - Chain or Independent PharmacyCode 3, 6B - Brand
Apr 01, 2022 $0.58438 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Feb 23, 2022 $0.54092 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Feb 23, 2022 $0.54092 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Aug 07, 2019 $0.55938 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Aug 07, 2019 $0.55938 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Aug 07, 2019 $0.55938 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Aug 07, 2019 $0.55938 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Mar 01, 2019 $0.55938 EAC/I - Chain or Independent PharmacyCode 3, 6B - Brand
Mar 01, 2019 $0.55938 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Mar 01, 2019 $0.55938 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Mar 01, 2019 $0.55938 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Mar 01, 2019 $0.55938 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Mar 01, 2019 $0.55938 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Mar 01, 2019 $0.55938 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Mar 01, 2019 $0.55938 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Feb 20, 2019 $0.50900 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Oct 17, 2018 $0.49750 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Oct 17, 2018 $0.49750 EAC/I - Chain or Independent PharmacyCode 2, 6B - Brand
Oct 17, 2018 $0.49750 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Oct 17, 2018 $0.49750 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: June 17, 2026